CYTORI THERAPEUTICS, INC. (CYTX) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 542 transactions totaling $23.4M, demonstrating a bullish sentiment with $14.6M in net insider flow. The most recent transaction on Feb 14, 2018 involved a sale of 473,831 shares valued at $161.1K.
No significant insider buying has been recorded for CYTX in the recent period.
No significant insider selling has been recorded for CYTX in the recent period.
Based on recent SEC filings, insider sentiment for CYTX is bullish with an Insider Alignment Score of 81/100 and a net flow of $14.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CYTORI THERAPEUTICS, INC. (CYTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading CYTX stock, having executed 542 transactions in the past 90 days. The most active insider is Corp Olympus (Executive), who has made 2 transactions totaling $17.0M.
Get notified when executives and directors at CYTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 14, 2018 | Postfinance Ag | Executive | Sale | 473,831 | $0.34 | $161.1K | |
| Feb 13, 2018 | Postfinance Ag | Executive | Sale | 101,710 | $0.31 | $31.5K | |
| Feb 12, 2018 | Postfinance Ag | Executive | Sale | 185,272 | $0.31 | $57.4K | |
| Feb 9, 2018 | Postfinance Ag | Executive | Sale | 7,552 | $0.34 | $2.6K | |
| Feb 8, 2018 | Postfinance Ag | Executive | Sale | 228,603 | $0.34 | $77.7K | |
| Jan 11, 2018 | Sa Swissquote Bank | Executive | Sale | 20,000 | $0.34 | $6.8K | |
| Jan 11, 2018 | Sa Swissquote Bank | Executive | Sale | 12,630 | $0.34 | $4.3K | |
| Jan 11, 2018 | Sa Swissquote Bank | Executive | Sale | 20,000 | $0.34 | $6.8K | |
| Jan 11, 2018 | Sa Swissquote Bank | Executive | Sale | 20,000 | $0.34 | $6.8K | |
| Jan 10, 2018 | Sa Swissquote Bank | Executive | Sale | 15,796 | $0.38 | $6.0K | |
| Jan 9, 2018 | Sa Swissquote Bank | Executive | Sale | 20,000 | $0.37 | $7.4K | |
| Jan 9, 2018 | Sa Swissquote Bank | Executive | Sale | 20,000 | $0.38 | $7.6K | |
| Jan 9, 2018 | Sa Swissquote Bank | Executive | Sale | 20,000 | $0.38 | $7.6K | |
| Jan 9, 2018 | Sa Swissquote Bank | Executive | Sale | 20,000 | $0.40 | $8.0K | |
| Jan 9, 2018 | Sa Swissquote Bank | Executive | Sale | 20,000 | $0.39 | $7.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 262 | $19.0M | 75.6% |
Sale(S) | 142 | $4.4M | 17.5% |
Exercise(M) | 47 | $1.4M | 5.6% |
Payment(F) | 1 | $178.4K | 0.7% |
Award(A) | 68 | $109.8K | 0.4% |
Exercise (Options)(X) | 10 | $20.1K | 0.1% |
Gift(G) | 3 | $0 | 0.0% |
Disposition(D) | 9 | $0 | 0.0% |
Insiders at CYTORI THERAPEUTICS, INC. are accumulating shares at an accelerated pace. With 24 insiders making 542 transactions totaling $19.0M in purchases versus $4.4M in sales, the net buying activity of $14.6M signals strong executive confidence. Corp Olympus (Executive) leads the buying activity with $17.0M in transactions across all time.